Trial · NCT07908199
Oura Ring OA15 Validation
NCT07908199, Recruiting, Ouraring Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Oura Ring OA15 Validation. Trials, record NCT07908199. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908199
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Oura Ring OA15 Validation
- NCT number
- NCT07908199
- Status
- Recruiting
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Ouraring Inc.
- Conditions
- Healthy Adult, Sleep Apnea
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sleep staging performance (co-primary endpoint) | Single time-point assessment post-overnight-PSG visit (baseline). | Agreement between Oura Ring sleep stage output and adjudicated PSG sleep stage scoring across the overnight in-laboratory recording (quantified by overall accuracy, Cohen's kappa, and class-specific sensitivity, specificity, positive predictive value, and F1 score for Wake, REM, and NREM sleep). |
| Primary | Signal quality performance (co-primary endpoint) | Single time-point assessment post-overnight-PSG visit (baseline). | Signal-to-noise ratio for overnight SpO2 signal quality. |
| Secondary | Respiratory event detection performance - apnea events | Single time-point assessment post-overnight-PSG visit (baseline). | Event-level detection of PSG-scored apnea events by Oura Ring, quantified by sensitivity, positive predictive value, false positive rate per hour, and F1 score. |
| Secondary | Respiratory event detection performance - hypopnea events | Single time-point assessment post-overnight-PSG visit (baseline). | Event-level detection of PSG-scored hypopnea events by Oura Ring, quantified by sensitivity, positive predictive value, false positive rate per hour, and F1 score. |
| Secondary | Respiratory event detection performance - oxygen desaturation events | Single time-point assessment post-overnight-PSG visit (baseline). | Event-level detection of PSG-scored oxygen desaturation events by Oura Ring, quantified by sensitivity, positive predictive value, false positive rate per hour, and F1 score. |
| Secondary | Overnight SpO2 agreement | Single time-point assessment post-overnight-PSG visit (baseline). | Agreement between Oura Ring overnight oxygen saturation estimates and PSG reference SpO2 measurements over matched overnight intervals, which may be quantified by mean bias, mean absolute error, root mean squared error, correlation, and Bland-Altman limits of agreement. |
| Secondary | Overnight heart rate and HRV agreement | Single time-point assessment post-overnight-PSG visit (baseline). | Agreement between Oura Ring overnight heart rate and heart rate variability estimates and ECG-derived reference metrics over matched overnight intervals, which may be quantified by mean bias, mean absolute error, root mean squared error, correlation, and Bland-Altman limits of agreement. |
| Secondary | Data completion (proportion of overnight recording time) | Single time-point assessment post-overnight-PSG visit (baseline). | Proportion of intended overnight recording time yielding valid Oura outputs (across sleep staging, heart rate, heart rate variability, SpO2, and Sleep Apnea Risk). |
| Secondary | Data completion (proportion of participants with complete datasets) | Single time-point assessment post-overnight-PSG visit (baseline). | Proportion of participants contributing analyzable data for all Oura outputs (sleep staging, heart rate, heart rate variability, SpO2, and sleep apnea risk). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908199
GET https://conductscience.org/api/trials/v1/NCT07908199/registered